SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tuck3/21/2019 9:57:24 AM
  Read Replies (2) of 3158
 
OK, so given the original purpose of this thread was to find prey before the predators got it . . . Who are the expected munchees after Biogen has a major clinical failure and has to flesh out the pipeline? With BIIB down in excess of 25% not all biotechs in the neuro space are down. SRPT, NBIX, and SAGE are up noticeably. perhaps there are others not on my radar. Anyone still here to throw out ideas aside from the above?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News